| scholarly article | Q13442814 |
| P2093 | author name string | Jing Chen | |
| Bo Xie | |||
| Yan Shu | |||
| Zhen Liang | |||
| Ligang Ren | |||
| P2860 | cites work | hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase | Q24291829 |
| SIRT1 promotes DNA repair activity and deacetylation of Ku70 | Q24298814 | ||
| SIRT1 interacts with p73 and suppresses p73-dependent transcriptional activity | Q24304342 | ||
| BOK and NOXA are essential mediators of p53-dependent apoptosis | Q24337595 | ||
| MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
| Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers | Q24625794 | ||
| Role of microRNAs in the resistance of prostate cancer to docetaxel and paclitaxel | Q26769599 | ||
| Role of microRNAs in chemoresistance | Q26770485 | ||
| Insights into Chemoresistance of Prostate Cancer | Q26795589 | ||
| Cancer statistics, 2015 | Q27860576 | ||
| The functions of animal microRNAs | Q27860621 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| p53 Acetylation: Regulation and Consequences | Q28085076 | ||
| Sirtuins in mammals: insights into their biological function | Q29615248 | ||
| β2-AR activation induces chemoresistance by modulating p53 acetylation through upregulating Sirt1 in cervical cancer cells | Q33873143 | ||
| Harnessing the p53-PUMA axis to overcome DNA damage resistance in renal cell carcinoma | Q35022460 | ||
| SIRT1 expression is associated with the chemotherapy response and prognosis of patients with advanced NSCLC. | Q35041187 | ||
| Sildenafil (Viagra) sensitizes prostate cancer cells to doxorubicin-mediated apoptosis through CD95 | Q36782452 | ||
| The role of chemotherapy and new targeted agents in the management of primary prostate cancer | Q37708171 | ||
| MicroRNAs and drug resistance in prostate cancers | Q38205266 | ||
| p53 as a target for the treatment of cancer. | Q38279586 | ||
| Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance. | Q38546133 | ||
| MicroRNA-22 inhibits cell growth and metastasis in breast cancer via targeting of SIRT1. | Q38638014 | ||
| MicroRNA-138 inhibits cell proliferation in hepatocellular carcinoma by targeting Sirt1. | Q38662706 | ||
| miR-15a/miR-16 down-regulates BMI1, impacting Ub-H2A mediated DNA repair and breast cancer cell sensitivity to doxorubicin | Q38706087 | ||
| TRIMming p53's anticancer activity | Q38742837 | ||
| Combining p53 stabilizers with metformin induces synergistic apoptosis through regulation of energy metabolism in castration-resistant prostate cancer | Q38792069 | ||
| MicroRNA-101 sensitizes hepatocellular carcinoma cells to doxorubicin-induced apoptosis via targeting Mcl-1. | Q38807863 | ||
| The miR-204-3p-targeted IGFBP2 pathway is involved in xanthohumol-induced glioma cell apoptotic death. | Q38834894 | ||
| Synergy of BID with doxorubicin in the killing of cancer cells | Q38901240 | ||
| miR-204-5p inhibits proliferation and invasion and enhances chemotherapeutic sensitivity of colorectal cancer cells by downregulating RAB22A. | Q38949787 | ||
| MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome | Q39297570 | ||
| Role of sirtuin histone deacetylase SIRT1 in prostate cancer. A target for prostate cancer management via its inhibition? | Q39905924 | ||
| SIRT1 promotes epithelial-mesenchymal transition and metastasis in colorectal cancer by regulating Fra-1 expression | Q39921520 | ||
| Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa | Q40066192 | ||
| SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress | Q40398454 | ||
| Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway. | Q40977712 | ||
| MiR-24-BIM-Smac/DIABLO axis controls the sensitivity to doxorubicin treatment in osteosarcoma | Q41215178 | ||
| Knockdown of miR-27a sensitizes colorectal cancer stem cells to TRAIL by promoting the formation of Apaf-1-caspase-9 complex | Q41233246 | ||
| microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression | Q41875279 | ||
| The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer. | Q53220492 | ||
| P433 | issue | 57 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 97313-97322 | |
| P577 | publication date | 2017-10-23 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | MiR-204 enhances mitochondrial apoptosis in doxorubicin-treated prostate cancer cells by targeting SIRT1/p53 pathway | |
| P478 | volume | 8 |
| Q92471621 | Down-regulation of long non-coding RNA HOTAIR inhibits invasion and migration of oesophageal cancer cells via up-regulation of microRNA-204 |
| Q97882657 | HBx mediated Increase of SIRT1 Contributes to HBV-related Hepatocellular Carcinoma Tumorigenesis |
| Q92382932 | Long non-coding RNA MALAT1 activates autophagy and promotes cell proliferation by downregulating microRNA-204 expression in gastric cancer |
| Q98945434 | MiR-140 Resensitizes Cisplatin-Resistant NSCLC Cells to Cisplatin Treatment Through the SIRT1/ROS/JNK Pathway |
| Q58795281 | MiR-204 acts as a potential therapeutic target in acute myeloid leukemia by increasing BIRC6-mediated apoptosis |
| Q92952317 | MiR-204 suppresses cell proliferation and promotes apoptosis in ovarian granulosa cells via targeting TPT1 in polycystic ovary syndrome |
| Q90642832 | MicroRNA-204 may participate in the pathogenesis of hypoxic-ischemic encephalopathy through targeting KLLN |
| Q102323862 | microRNA-211-mediated targeting of the INHBA-TGF-β axis suppresses prostate tumor formation and growth |
Search more.